25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biomind Labs Inc
Buy, Hold or Sell?

Let's analyze Biomind Labs Inc together

I guess you are interested in Biomind Labs Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biomind Labs Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biomind Labs Inc

I send you an email if I find something interesting about Biomind Labs Inc.

Quick analysis of Biomind Labs Inc (30 sec.)










What can you expect buying and holding a share of Biomind Labs Inc? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.03
Expected worth in 1 year
C$-0.05
How sure are you?
8.3%

+ What do you gain per year?

Total Gains per Share
C$-0.02
Return On Investment
-2.5%

For what price can you sell your share?

Current Price per Share
C$0.74
Expected price per share
C$0.025 - C$1.59
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Biomind Labs Inc (5 min.)




Live pricePrice per Share (EOD)

C$0.74

2. Growth of Biomind Labs Inc (5 min.)




Is Biomind Labs Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.6m$97.8k-$1.3m-107.6%

How much money is Biomind Labs Inc making?

Current yearPrevious yearGrowGrow %
Making money-$236.1k-$677k$440.8k186.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Biomind Labs Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#853 / 982

Most Revenue
#927 / 982

Most Profit
#173 / 982

Most Efficient
#277 / 982
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Biomind Labs Inc? (5 min.)

Welcome investor! Biomind Labs Inc's management wants to use your money to grow the business. In return you get a share of Biomind Labs Inc.

What can you expect buying and holding a share of Biomind Labs Inc?

First you should know what it really means to hold a share of Biomind Labs Inc. And how you can make/lose money.

Speculation

The Price per Share of Biomind Labs Inc is C$0.74. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biomind Labs Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biomind Labs Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.03. Based on the TTM, the Book Value Change Per Share is C$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biomind Labs Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.00-0.3%0.00-0.4%-0.01-1.2%-0.01-1.3%-0.01-1.3%
Usd Book Value Change Per Share0.00-0.4%0.00-0.5%-0.01-1.1%0.00-0.2%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.4%0.00-0.5%-0.01-1.1%0.00-0.2%0.00-0.2%
Usd Price Per Share0.31-0.22-0.66-0.55-0.55-
Price to Earnings Ratio-31.14--21.12--18.06--16.75--16.75-
Price-to-Total Gains Ratio-114.00--77.43--83.57--78.49--78.49-
Price to Book Ratio-14.18--13.53-36.81-16.56-16.56-
Price-to-Total Gains Ratio-114.00--77.43--83.57--78.49--78.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.539978
Number of shares1851
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (1851 shares)-6.17-3.37
Gains per Year (1851 shares)-24.69-13.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-25-350-13-23
20-49-600-27-36
30-74-850-40-49
40-99-1100-54-62
50-123-1350-67-75
60-148-1600-81-88
70-173-1850-94-101
80-198-2100-108-114
90-222-2350-121-127
100-247-2600-135-140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.012.00.00.0%0.012.00.00.0%0.012.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%1.011.00.08.3%1.011.00.08.3%1.011.00.08.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.012.00.0%0.00.012.00.0%0.00.012.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%1.011.00.08.3%1.011.00.08.3%1.011.00.08.3%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Biomind Labs Inc

About Biomind Labs Inc

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammatory disorders, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay.

Fundamental data was last updated by Penke on 2024-07-18 19:04:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Biomind Labs Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biomind Labs Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biomind Labs Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biomind Labs Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--169.1%+169.1%
TTM--209.9%+209.9%
YOY--234.9%+234.9%
5Y--392.9%+392.9%
10Y--512.4%+512.4%
1.1.2. Return on Assets

Shows how efficient Biomind Labs Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biomind Labs Inc to the Biotechnology industry mean.
  • -254.0% Return on Assets means that Biomind Labs Inc generated $-2.54 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biomind Labs Inc:

  • The MRQ is -254.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -257.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-254.0%TTM-257.3%+3.3%
TTM-257.3%YOY-351.4%+94.1%
TTM-257.3%5Y-240.7%-16.6%
5Y-240.7%10Y-240.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-254.0%-11.8%-242.2%
TTM-257.3%-11.9%-245.4%
YOY-351.4%-11.2%-340.2%
5Y-240.7%-13.3%-227.4%
10Y-240.7%-14.7%-226.0%
1.1.3. Return on Equity

Shows how efficient Biomind Labs Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biomind Labs Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Biomind Labs Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biomind Labs Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-128.4%+128.4%
TTM-5Y-58.4%+58.4%
5Y-58.4%10Y-58.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.1%+14.1%
TTM--15.2%+15.2%
YOY-128.4%-14.0%-114.4%
5Y-58.4%-18.8%-39.6%
10Y-58.4%-19.4%-39.0%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Biomind Labs Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biomind Labs Inc is operating .

  • Measures how much profit Biomind Labs Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biomind Labs Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biomind Labs Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--346.7%+346.7%
TTM--218.9%+218.9%
YOY--238.4%+238.4%
5Y--400.7%+400.7%
10Y--514.0%+514.0%
1.2.2. Operating Ratio

Measures how efficient Biomind Labs Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biomind Labs Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.003-3.003
TTM-3.247-3.247
YOY-3.454-3.454
5Y-5.124-5.124
10Y-6.570-6.570
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Biomind Labs Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biomind Labs Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.03 means the company has $0.03 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biomind Labs Inc:

  • The MRQ is 0.027. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.058. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.027TTM0.058-0.030
TTM0.058YOY2.994-2.937
TTM0.0585Y3.695-3.637
5Y3.69510Y3.6950.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0273.793-3.766
TTM0.0584.066-4.008
YOY2.9944.958-1.964
5Y3.6955.996-2.301
10Y3.6956.335-2.640
1.3.2. Quick Ratio

Measures if Biomind Labs Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biomind Labs Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biomind Labs Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.192-3.192
TTM-3.581-3.581
YOY-4.835-4.835
5Y-5.948-5.948
10Y-6.457-6.457
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Biomind Labs Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biomind Labs Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biomind Labs Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 23.32 means that Biomind Labs Inc assets are financed with 2,331.6% credit (debt) and the remaining percentage (100% - 2,331.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biomind Labs Inc:

  • The MRQ is 23.316. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 15.394. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ23.316TTM15.394+7.922
TTM15.394YOY3.424+11.969
TTM15.3945Y6.917+8.476
5Y6.91710Y6.9170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.3160.328+22.988
TTM15.3940.339+15.055
YOY3.4240.286+3.138
5Y6.9170.367+6.550
10Y6.9170.383+6.534
1.4.2. Debt to Equity Ratio

Measures if Biomind Labs Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biomind Labs Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biomind Labs Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.388-0.388
TTM-5Y0.156-0.156
5Y0.15610Y0.1560.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.363-0.363
TTM-0.412-0.412
YOY0.3880.367+0.021
5Y0.1560.438-0.282
10Y0.1560.476-0.320
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Biomind Labs Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biomind Labs Inc generates.

  • Above 15 is considered overpriced but always compare Biomind Labs Inc to the Biotechnology industry mean.
  • A PE ratio of -31.14 means the investor is paying $-31.14 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biomind Labs Inc:

  • The EOD is -54.228. Based on the earnings, the company is expensive. -2
  • The MRQ is -31.144. Based on the earnings, the company is expensive. -2
  • The TTM is -21.117. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-54.228MRQ-31.144-23.083
MRQ-31.144TTM-21.117-10.027
TTM-21.117YOY-18.056-3.061
TTM-21.1175Y-16.748-4.369
5Y-16.74810Y-16.7480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-54.228-2.652-51.576
MRQ-31.144-3.015-28.129
TTM-21.117-2.881-18.236
YOY-18.056-3.574-14.482
5Y-16.748-6.225-10.523
10Y-16.748-6.348-10.400
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biomind Labs Inc:

  • The EOD is -87.446. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -50.222. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -29.782. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-87.446MRQ-50.222-37.224
MRQ-50.222TTM-29.782-20.441
TTM-29.782YOY-28.946-0.835
TTM-29.7825Y-24.747-5.034
5Y-24.74710Y-24.7470.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-87.446-3.251-84.195
MRQ-50.222-3.787-46.435
TTM-29.782-3.794-25.988
YOY-28.946-5.044-23.902
5Y-24.747-8.020-16.727
10Y-24.747-8.669-16.078
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biomind Labs Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -14.18 means the investor is paying $-14.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biomind Labs Inc:

  • The EOD is -24.689. Based on the equity, the company is expensive. -2
  • The MRQ is -14.179. Based on the equity, the company is expensive. -2
  • The TTM is -13.534. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-24.689MRQ-14.179-10.509
MRQ-14.179TTM-13.534-0.645
TTM-13.534YOY36.808-50.342
TTM-13.5345Y16.557-30.091
5Y16.55710Y16.5570.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-24.6891.991-26.680
MRQ-14.1792.271-16.450
TTM-13.5342.296-15.830
YOY36.8082.385+34.423
5Y16.5573.670+12.887
10Y16.5574.162+12.395
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biomind Labs Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.005+23%-0.011+188%-0.002-33%-0.002-33%
Book Value Per Share---0.030-0.024-21%0.002-1771%0.002-1499%0.002-1499%
Current Ratio--0.0270.058-53%2.994-99%3.695-99%3.695-99%
Debt To Asset Ratio--23.31615.394+51%3.424+581%6.917+237%6.917+237%
Debt To Equity Ratio----0%0.388-100%0.156-100%0.156-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.003-0.004+27%-0.012+264%-0.013+279%-0.013+279%
Free Cash Flow Per Share---0.002-0.003+35%-0.008+268%-0.008+275%-0.008+275%
Free Cash Flow To Equity Per Share--0.0000.000-59%-0.007+1294%0.000-471%0.000-471%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap55323808.960+43%31773809.20022895833.100+39%67285713.600-53%56787896.247-44%56787896.247-44%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-24.689-74%-14.179-13.534-5%36.808-139%16.557-186%16.557-186%
Pe Ratio-54.228-74%-31.144-21.117-32%-18.056-42%-16.748-46%-16.748-46%
Price Per Share0.740+43%0.4250.306+39%0.900-53%0.760-44%0.760-44%
Price To Free Cash Flow Ratio-87.446-74%-50.222-29.782-41%-28.946-42%-24.747-51%-24.747-51%
Price To Total Gains Ratio-198.490-74%-113.998-77.433-32%-83.571-27%-78.491-31%-78.491-31%
Quick Ratio----0%-0%-0%-0%
Return On Assets---2.540-2.573+1%-3.514+38%-2.407-5%-2.407-5%
Return On Equity----0%-1.2840%-0.5840%-0.5840%
Total Gains Per Share---0.004-0.005+23%-0.011+188%-0.002-33%-0.002-33%
Usd Book Value---1635163.689-1289826.410-21%97826.959-1771%116874.757-1499%116874.757-1499%
Usd Book Value Change Per Share---0.003-0.003+23%-0.008+188%-0.002-33%-0.002-33%
Usd Book Value Per Share---0.022-0.017-21%0.001-1771%0.002-1499%0.002-1499%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.002-0.003+27%-0.009+264%-0.009+279%-0.009+279%
Usd Free Cash Flow---115413.522-156382.267+35%-424797.361+268%-433185.698+275%-433185.698+275%
Usd Free Cash Flow Per Share---0.002-0.002+35%-0.006+268%-0.006+275%-0.006+275%
Usd Free Cash Flow To Equity Per Share--0.0000.000-59%-0.005+1294%0.000-471%0.000-471%
Usd Market Cap40369783.398+43%23185348.57316707089.413+39%49098385.214-53%41438127.891-44%41438127.891-44%
Usd Price Per Share0.540+43%0.3100.223+39%0.657-53%0.554-44%0.554-44%
Usd Profit---186112.689-236180.269+27%-677053.053+264%-704591.579+279%-704591.579+279%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.003-0.003+23%-0.008+188%-0.002-33%-0.002-33%
 EOD+6 -2MRQTTM+17 -9YOY+18 -95Y+11 -1610Y+11 -16

3.2. Fundamental Score

Let's check the fundamental score of Biomind Labs Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-54.228
Price to Book Ratio (EOD)Between0-1-24.689
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.027
Debt to Asset Ratio (MRQ)Less than123.316
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.540
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Biomind Labs Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.250
Ma 20Greater thanMa 500.487
Ma 50Greater thanMa 1000.379
Ma 100Greater thanMa 2000.380
OpenGreater thanClose0.580
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets73
Total Liabilities1,709
Total Stockholder Equity-1,636
 As reported
Total Liabilities 1,709
Total Stockholder Equity+ -1,636
Total Assets = 73

Assets

Total Assets73
Total Current Assets47
Long-term Assets27
Total Current Assets
Cash And Cash Equivalents 47
Total Current Assets  (as reported)47
Total Current Assets  (calculated)47
+/-0
Long-term Assets
Property Plant Equipment 27
Long-term Assets  (as reported)27
Long-term Assets  (calculated)27
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,709
Long-term Liabilities0
Total Stockholder Equity-1,636
Total Current Liabilities
Short Long Term Debt 883
Other Current Liabilities 234
Total Current Liabilities  (as reported)1,709
Total Current Liabilities  (calculated)1,118
+/- 591
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)-1,636
Total Stockholder Equity (calculated)0
+/- 1,636
Other
Capital Stock11,102
Common Stock Shares Outstanding 74,762
Net Debt 837
Net Invested Capital -752
Net Working Capital -1,662
Property Plant and Equipment Gross 45



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-31
> Total Assets 
0
98
3,222
2,528
1,808
1,174
518
89
78
110
158
74
73
737415811078895181,1741,8082,5283,222980
   > Total Current Assets 
67
37
2,440
2,440
1,731
1,108
464
45
44
79
129
45
47
47451297944454641,1081,7312,4402,4403767
       Cash And Cash Equivalents 
0
15
3,124
2,274
1,609
1,031
405
26
14
61
129
24
47
47241296114264051,0311,6092,2743,124150
   > Long-term Assets 
0
62
53
88
77
66
54
44
33
31
29
29
27
2729293133445466778853620
       Property Plant Equipment 
0
62
88
88
77
0
54
44
33
31
29
29
27
272929313344540778888620
> Total Liabilities 
0
732
311
335
106
108
307
337
716
1,084
1,277
1,506
1,709
1,7091,5061,2771,0847163373071081063353117320
   > Total Current Liabilities 
98
705
325
325
101
108
307
337
716
1,084
1,277
1,506
1,709
1,7091,5061,2771,08471633730710810132532570598
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
739
883
88373900000000000
       Accounts payable 
68
669
290
290
66
0
0
0
0
0
0
0
0
000000006629029066968
       Other Current Liabilities 
0
0
0
0
0
0
0
0
277
436
665
206
234
23420666543627700000000
   > Long-term Liabilities 
0
27
19
10
4
0
0
0
0
0
0
0
0
0000000041019270
> Total Stockholder Equity
0
-634
2,910
2,193
1,702
1,066
212
-248
-638
-974
-1,119
-1,432
-1,636
-1,636-1,432-1,119-974-638-2482121,0661,7022,1932,910-6340
   Common Stock
1,447
5,925
11,102
11,102
11,102
0
0
0
0
0
0
0
0
0000000011,10211,10211,1025,9251,447
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 0000000000000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
-92
132
1,537
1,537
95
0
0
0
0
0
0
0
0
00000000951,5371,537132-92



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-991
Operating Income-991-991
 
Operating Expense (+$)
Research Development307
Selling General Administrative669
Selling And Marketing Expenses-
Operating Expense991976
 
Net Interest Income (+$)
Interest Income-
Interest Expense-161
Other Finance Cost-0
Net Interest Income-161
 
Pretax Income (+$)
Operating Income-991
Net Interest Income-161
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,192-952
EBIT - interestExpense = -161
-1,192
-1,031
Interest Expense161
Earnings Before Interest and Taxes (EBIT)--1,031
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,192
Tax Provision--
Net Income From Continuing Ops-1,192-1,192
Net Income-1,192
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-40161
 

Technical Analysis of Biomind Labs Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biomind Labs Inc. The general trend of Biomind Labs Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biomind Labs Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biomind Labs Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.09 < 1.59.

The bearish price targets are: 0.1 > 0.09 > 0.025.

Tweet this
Biomind Labs Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biomind Labs Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biomind Labs Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biomind Labs Inc. The current macd is 0.06198421.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biomind Labs Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biomind Labs Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biomind Labs Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biomind Labs Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiomind Labs Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biomind Labs Inc. The current adx is 50.41.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biomind Labs Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Biomind Labs Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biomind Labs Inc. The current sar is 1.03565771.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biomind Labs Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biomind Labs Inc. The current rsi is 57.25. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Biomind Labs Inc Daily Relative Strength Index (RSI) ChartBiomind Labs Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biomind Labs Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biomind Labs Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biomind Labs Inc Daily Stochastic Oscillator ChartBiomind Labs Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biomind Labs Inc. The current cci is 103.14.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Biomind Labs Inc Daily Commodity Channel Index (CCI) ChartBiomind Labs Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biomind Labs Inc. The current cmo is 18.33.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Biomind Labs Inc Daily Chande Momentum Oscillator (CMO) ChartBiomind Labs Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biomind Labs Inc. The current willr is -40.22988506.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biomind Labs Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biomind Labs Inc Daily Williams %R ChartBiomind Labs Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biomind Labs Inc.

Biomind Labs Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biomind Labs Inc. The current atr is 0.16088664.

Biomind Labs Inc Daily Average True Range (ATR) ChartBiomind Labs Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biomind Labs Inc. The current obv is 137,563.

Biomind Labs Inc Daily On-Balance Volume (OBV) ChartBiomind Labs Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biomind Labs Inc. The current mfi is 90.12.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Biomind Labs Inc Daily Money Flow Index (MFI) ChartBiomind Labs Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biomind Labs Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Biomind Labs Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biomind Labs Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.250
Ma 20Greater thanMa 500.487
Ma 50Greater thanMa 1000.379
Ma 100Greater thanMa 2000.380
OpenGreater thanClose0.580
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biomind Labs Inc with someone you think should read this too:
  • Are you bullish or bearish on Biomind Labs Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biomind Labs Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biomind Labs Inc

I send you an email if I find something interesting about Biomind Labs Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biomind Labs Inc.

Receive notifications about Biomind Labs Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.